14-19876423-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005501.2(OR4K2):āc.156C>Gā(p.Asp52Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000632 in 1,613,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001005501.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4K2 | NM_001005501.2 | c.156C>G | p.Asp52Glu | missense_variant | 2/2 | ENST00000641885.1 | NP_001005501.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4K2 | ENST00000641885.1 | c.156C>G | p.Asp52Glu | missense_variant | 2/2 | NM_001005501.2 | ENSP00000493007.1 | |||
OR4K2 | ENST00000298642.2 | c.156C>G | p.Asp52Glu | missense_variant | 1/1 | 6 | ENSP00000298642.2 | |||
OR4K2 | ENST00000641522.1 | n.1133+39C>G | intron_variant | |||||||
OR4K2 | ENST00000641785.1 | n.1133+39C>G | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251370Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135852
GnomAD4 exome AF: 0.0000684 AC: 100AN: 1461790Hom.: 0 Cov.: 35 AF XY: 0.0000591 AC XY: 43AN XY: 727202
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.156C>G (p.D52E) alteration is located in exon 1 (coding exon 1) of the OR4K2 gene. This alteration results from a C to G substitution at nucleotide position 156, causing the aspartic acid (D) at amino acid position 52 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at